David Hyun Jung, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ear, Inner | 5 | 2022 | 426 | 2.170 |
Why?
|
| Labyrinth Diseases | 6 | 2018 | 151 | 1.850 |
Why?
|
| Hearing Loss, Sensorineural | 5 | 2023 | 783 | 1.610 |
Why?
|
| Hearing Loss | 10 | 2020 | 786 | 1.500 |
Why?
|
| Diphosphonates | 4 | 2018 | 635 | 1.200 |
Why?
|
| Temporal Bone | 11 | 2022 | 683 | 1.190 |
Why?
|
| Cochlea | 8 | 2023 | 846 | 1.120 |
Why?
|
| Neuroma, Acoustic | 2 | 2022 | 458 | 1.110 |
Why?
|
| Otosclerosis | 3 | 2016 | 113 | 1.070 |
Why?
|
| Hearing | 5 | 2023 | 502 | 1.050 |
Why?
|
| Imidazoles | 3 | 2016 | 1174 | 1.010 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 3 | 2021 | 88 | 0.970 |
Why?
|
| Vestibular Nerve | 2 | 2019 | 101 | 0.810 |
Why?
|
| Semicircular Canals | 5 | 2021 | 203 | 0.770 |
Why?
|
| Hearing Loss, Sudden | 1 | 2020 | 45 | 0.700 |
Why?
|
| Endolymphatic Sac | 1 | 2018 | 49 | 0.600 |
Why?
|
| Ear Neoplasms | 1 | 2018 | 118 | 0.600 |
Why?
|
| Otologic Surgical Procedures | 2 | 2020 | 150 | 0.580 |
Why?
|
| Meniere Disease | 2 | 2018 | 164 | 0.580 |
Why?
|
| Oval Window, Ear | 1 | 2016 | 21 | 0.530 |
Why?
|
| Audiometry | 6 | 2018 | 253 | 0.520 |
Why?
|
| Cogan Syndrome | 1 | 2015 | 10 | 0.510 |
Why?
|
| Cochlear Implantation | 4 | 2022 | 319 | 0.510 |
Why?
|
| Tinnitus | 4 | 2023 | 197 | 0.490 |
Why?
|
| Pharmaceutical Preparations | 3 | 2023 | 1089 | 0.470 |
Why?
|
| Facial Nerve | 1 | 2017 | 277 | 0.470 |
Why?
|
| Recombination, Genetic | 5 | 2009 | 1526 | 0.470 |
Why?
|
| Hearing Disorders | 1 | 2015 | 126 | 0.470 |
Why?
|
| Electrophysiology | 1 | 2017 | 1266 | 0.450 |
Why?
|
| Facial Paralysis | 1 | 2017 | 346 | 0.420 |
Why?
|
| Cochlear Implants | 3 | 2022 | 343 | 0.400 |
Why?
|
| Dizziness | 1 | 2015 | 269 | 0.380 |
Why?
|
| Vasculitis | 1 | 2015 | 524 | 0.370 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2009 | 420 | 0.360 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2009 | 19 | 0.340 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2009 | 10 | 0.340 |
Why?
|
| Hyperacusis | 2 | 2020 | 31 | 0.330 |
Why?
|
| Aerosols | 3 | 2021 | 637 | 0.330 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2015 | 1734 | 0.320 |
Why?
|
| VDJ Recombinases | 2 | 2009 | 84 | 0.310 |
Why?
|
| Bone Density Conservation Agents | 1 | 2016 | 797 | 0.310 |
Why?
|
| Genes, Immunoglobulin | 2 | 2006 | 286 | 0.300 |
Why?
|
| Employment | 1 | 2012 | 1120 | 0.260 |
Why?
|
| Vestibular Diseases | 2 | 2019 | 232 | 0.260 |
Why?
|
| Spiral Ganglion | 2 | 2023 | 177 | 0.230 |
Why?
|
| Genes, RAG-1 | 1 | 2004 | 68 | 0.230 |
Why?
|
| Guinea Pigs | 2 | 2016 | 1310 | 0.230 |
Why?
|
| Hair Cells, Auditory, Inner | 2 | 2023 | 197 | 0.230 |
Why?
|
| Income | 1 | 2012 | 1878 | 0.220 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2006 | 648 | 0.220 |
Why?
|
| Genes, T-Cell Receptor beta | 2 | 2003 | 70 | 0.220 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2023 | 33 | 0.220 |
Why?
|
| Mastoid | 2 | 2020 | 100 | 0.220 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2020 | 210 | 0.200 |
Why?
|
| Research Design | 1 | 2018 | 6217 | 0.200 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 8051 | 0.200 |
Why?
|
| Drugs, Investigational | 1 | 2023 | 213 | 0.190 |
Why?
|
| Fractures, Bone | 5 | 2019 | 2063 | 0.180 |
Why?
|
| Leukocidins | 1 | 2020 | 18 | 0.180 |
Why?
|
| Hemolysin Proteins | 1 | 2020 | 113 | 0.170 |
Why?
|
| Retrospective Studies | 12 | 2022 | 81834 | 0.160 |
Why?
|
| Cadaver | 3 | 2020 | 1362 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 36840 | 0.160 |
Why?
|
| Endolymphatic Hydrops | 1 | 2018 | 31 | 0.150 |
Why?
|
| Ear Diseases | 1 | 2020 | 181 | 0.150 |
Why?
|
| Drug Delivery Systems | 3 | 2018 | 2238 | 0.150 |
Why?
|
| Speech Perception | 1 | 2022 | 512 | 0.140 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 227 | 0.140 |
Why?
|
| Receptor, trkB | 1 | 2018 | 125 | 0.140 |
Why?
|
| Humans | 36 | 2023 | 768451 | 0.140 |
Why?
|
| Vestibule, Labyrinth | 1 | 2018 | 235 | 0.130 |
Why?
|
| Auditory Perception | 2 | 2023 | 588 | 0.130 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2016 | 139 | 0.130 |
Why?
|
| Skull Base | 1 | 2018 | 294 | 0.130 |
Why?
|
| Auditory Brain Stem Implantation | 1 | 2015 | 15 | 0.120 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2015 | 53 | 0.120 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 562 | 0.120 |
Why?
|
| Diffusion | 1 | 2016 | 818 | 0.120 |
Why?
|
| Craniocerebral Trauma | 1 | 2018 | 496 | 0.110 |
Why?
|
| Cochlear Nerve | 1 | 2015 | 202 | 0.110 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 2003 | 94 | 0.110 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2015 | 326 | 0.100 |
Why?
|
| Decompression, Surgical | 1 | 2017 | 612 | 0.100 |
Why?
|
| Male | 17 | 2021 | 364781 | 0.100 |
Why?
|
| Disability Evaluation | 1 | 2019 | 1839 | 0.100 |
Why?
|
| Drug Design | 1 | 2016 | 1050 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 960 | 0.090 |
Why?
|
| Middle Aged | 12 | 2020 | 223418 | 0.090 |
Why?
|
| Animals | 14 | 2020 | 169418 | 0.090 |
Why?
|
| Auditory Threshold | 2 | 2023 | 369 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1818 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1977 | 0.080 |
Why?
|
| Antibody Diversity | 2 | 2006 | 72 | 0.080 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 2006 | 91 | 0.080 |
Why?
|
| Blotting, Southern | 1 | 2009 | 777 | 0.080 |
Why?
|
| Restriction Mapping | 1 | 2009 | 851 | 0.080 |
Why?
|
| Adult | 10 | 2023 | 223542 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2015 | 65409 | 0.080 |
Why?
|
| Chimera | 1 | 2009 | 454 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 20762 | 0.070 |
Why?
|
| Female | 15 | 2020 | 396943 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2019 | 1430 | 0.070 |
Why?
|
| Quality of Life | 3 | 2020 | 13497 | 0.070 |
Why?
|
| B-Lymphocytes | 3 | 2006 | 4781 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 3713 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 11930 | 0.060 |
Why?
|
| Aged | 8 | 2019 | 171520 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2006 | 3442 | 0.060 |
Why?
|
| Plasmids | 1 | 2009 | 2269 | 0.060 |
Why?
|
| Gene Rearrangement | 1 | 2009 | 1139 | 0.060 |
Why?
|
| Receptors, Antigen | 1 | 2004 | 51 | 0.060 |
Why?
|
| Models, Immunological | 1 | 2006 | 518 | 0.050 |
Why?
|
| Extrachromosomal Inheritance | 1 | 2003 | 18 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 13026 | 0.050 |
Why?
|
| TATA Box | 1 | 2003 | 127 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 9263 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
| Bionics | 1 | 2022 | 46 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Prognosis | 3 | 2018 | 30028 | 0.050 |
Why?
|
| Feedback | 1 | 2006 | 794 | 0.050 |
Why?
|
| Hearing Tests | 1 | 2022 | 123 | 0.050 |
Why?
|
| Otolaryngology | 2 | 2018 | 698 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2009 | 1884 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8753 | 0.040 |
Why?
|
| Fluorescein | 1 | 2020 | 175 | 0.040 |
Why?
|
| CHO Cells | 1 | 2003 | 1382 | 0.040 |
Why?
|
| Mice | 7 | 2018 | 82045 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 54914 | 0.040 |
Why?
|
| Cricetinae | 1 | 2003 | 2423 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 4175 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 3073 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2006 | 9558 | 0.040 |
Why?
|
| Prevalence | 1 | 2015 | 15880 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 290 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2018 | 617 | 0.030 |
Why?
|
| Adolescent | 4 | 2020 | 89168 | 0.030 |
Why?
|
| Young Adult | 3 | 2019 | 60045 | 0.030 |
Why?
|
| Acute Lung Injury | 1 | 2020 | 378 | 0.030 |
Why?
|
| Nervous System | 1 | 1999 | 547 | 0.030 |
Why?
|
| Neurites | 1 | 2018 | 391 | 0.030 |
Why?
|
| Patents as Topic | 1 | 2016 | 113 | 0.030 |
Why?
|
| Microscopy | 1 | 2020 | 909 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2022 | 1296 | 0.030 |
Why?
|
| Transfection | 1 | 2003 | 5767 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3735 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2018 | 1053 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2020 | 799 | 0.030 |
Why?
|
| Occupational Health | 1 | 2020 | 814 | 0.030 |
Why?
|
| DNA Damage | 1 | 2004 | 2461 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2018 | 709 | 0.030 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2015 | 255 | 0.030 |
Why?
|
| Rabbits | 1 | 2020 | 4786 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1629 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 2430 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 704 | 0.030 |
Why?
|
| Reoperation | 1 | 2022 | 4342 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2018 | 1146 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 1461 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2018 | 866 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2015 | 1253 | 0.020 |
Why?
|
| Research | 1 | 2018 | 1984 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1999 | 2858 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5996 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 3612 | 0.020 |
Why?
|
| Gene Targeting | 2 | 2003 | 842 | 0.020 |
Why?
|
| Models, Biological | 1 | 2004 | 9505 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 10273 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10601 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 9623 | 0.020 |
Why?
|
| Complementarity Determining Regions | 1 | 2005 | 150 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11138 | 0.010 |
Why?
|
| United States | 1 | 2012 | 73121 | 0.010 |
Why?
|
| Proteins | 1 | 1999 | 6008 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 59680 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14728 | 0.010 |
Why?
|
| Base Sequence | 2 | 2005 | 12428 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1999 | 7895 | 0.010 |
Why?
|
| Registries | 1 | 2018 | 8373 | 0.010 |
Why?
|
| Hybridomas | 1 | 2003 | 444 | 0.010 |
Why?
|
| DNA | 2 | 2005 | 7213 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18388 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22293 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15965 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10865 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 1999 | 152 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 808 | 0.010 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 1999 | 115 | 0.010 |
Why?
|
| Child | 2 | 2015 | 80863 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 6241 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 41797 | 0.010 |
Why?
|
| Neoplasms | 1 | 2004 | 22386 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 1814 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 1999 | 770 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 13452 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 3417 | 0.010 |
Why?
|
| Infant | 1 | 2015 | 36497 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2015 | 42623 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2005 | 14480 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2819 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1999 | 2882 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 11674 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 22365 | 0.000 |
Why?
|